PSKH1: A Promising Drug Target and Biomarker for the Treatment of Psychological Disorders

Target Name: PSKH1

NCBI ID: G5681

PSKH1

Other Name(s): protein serine kinase H1 | Serine/threonine-protein kinase H1 | KPSH1_HUMAN | Protein serine kinase H1 | PSK-H1

PSKH1: A Promising Drug Target and Biomarker for the Treatment of Psychological Disorders

Psychological disorders are a significant public health issue, affecting millions of individuals worldwide. The symptoms and consequences of these disorders can range from mild to severe, and their impact on an individual's quality of life can be significant. For instance, depression, anxiety, and

Protein Name: Protein Serine Kinase H1

Functions: May be a SFC-associated serine kinase (splicing factor compartment-associated serine kinase) with a role in intranuclear SR protein (non-snRNP splicing factors containing a serine/arginine-rich domain) trafficking and pre-mRNA processing

The "PSKH1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PSKH1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets